Call us
08045475302
250 MG Crizonitib Capsules are a medication formulated for oral administration, containing 250 mg of the active ingredient Crizotinib. These capsules are mainly used for the treatment of specific types of cancer, specifically non-small cell lung cancer (NSCLC) that is positive for an abnormal anaplastic lymphoma kinase (ALK) gene. 250 MG Crizonitib Capsules works best by inhibiting the activity of the abnormal ALK protein, which is responsible for promoting the growth and spread of cancer cells. By blocking this protein, Crizotinib helps to slow down or stop the progression of cancer.